Skip to content

John Oyler, Chief Executive Officer at BeOne Medicines, sold ONC on Jun 11, 2026

Data as of Oct 16

▼ SELL$190K741 shares at $256.23John Oyler Chief Executive OfficerONC BeOne Medicines Ltd.
Watch ONC
Traded
Jun 11, 2026
Disclosed
Jun 15, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

John Oyler, Chief Executive Officer at BeOne Medicines, sold ONC on Jun 11, 2026TRADEDDISCLOSED
ONCSimilar stocks (XLV — its sector index fund), rebased to ONC's price on the disclosure day
ONC since disclosure
+37.6%
after the sale
Similar stocks (XLV) since disclosure
+15.6%
XLV — its sector index fund

Change in closing price from Jun 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$51.7Kdisclosed Jun 15 · filed 4 days after the trade
  2. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$221Kdisclosed Jun 15 · filed 4 days after the trade
  3. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$38.6Kdisclosed Jun 15 · filed 4 days after the trade

See every trade on ONC →